DaVita Labs Expands Footprint in DeLand

Business, teammate growth drives need for new facility

News provided by

Apr 21, 2014, 10:03 ET

DELAND, Fla., April 21, 2014 /PRNewswire/ -- DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that DaVita Labs^SM, the diagnostic laboratory servicing both dialysis organizations and physician practices, is expanding its laboratory operations in DeLand, Fla., to accommodate future teammate growth.

"We are proud that DaVita Labs has decided to expand here in Florida. These 100 new jobs in the area means more Floridians will be able to provide for their families," said Florida Governor Rick Scott. "Together we are creating an opportunity economy where companies can expand and create more jobs for Florida families."

DaVita Labs performs more than 47 million laboratory tests each year and employs more than 500 teammates between Ft. Lauderdale and DeLand – a number that has grown by nearly 15 percent since the beginning of 2012. As part of this expansion, DaVita Labs will build a new 65,000-square-foot facility, with the opportunity for expansion to accommodate potential future growth. The construction is set to begin in mid-2014 with target completion date of early-to-mid 2015.

"At DaVita Labs we are dedicated not only to our patients and our teammates, but also to the communities we serve and live in," said DaVita Labs General Manager Jason Cline. "This expansion demonstrates our steadfast commitment to the City of DeLand and all of Volusia County, which has been an attractive location for recruiting and retaining teammates."

DaVita Labs currently has 137,000 square feet dedicated to its state-of-the-art clinical diagnostic laboratories between its two locations in Ft. Lauderdale and DeLand. The laboratories feature the latest in renal-specific methodology and technology for delivering quality test results. The DaVita Labs clinical laboratory team is led by experienced scientists and pathologists, and receives formal guidance from top nephrologists in the industry.

DaVita and DaVita Labs are trademarks or registered trademarks of DaVita HealthCare Partners Inc. All other trademarks are the property of their respective owners.

About DaVita Labs
DaVita Labs provides quality, on-time, accurate results to help effectively identify and manage kidney patients across the nation. As a cutting-edge chronic kidney disease (CKD) specialty laboratory, DaVita Labs features the latest in end stage renal disease-specific methodology and technology for delivering quality dialysis test results. DaVita Labs is fully accredited by the federal and state governmental agencies and the College of American Pathologists. For more information, please visit http://www.dvalab.com/ or call 877.200.3181.

About DaVita
DaVita Kidney Care is a division of DaVita HealthCare Partners Inc., a Fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of Dec. 31, 2013, DaVita Kidney Care operated or provided administrative services at 2,074 outpatient dialysis centers located in the United States serving approximately 163,000 patients. The company also operated 73 outpatient dialysis centers located in 10 countries outside the United States. DaVita Kidney Care supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company's leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visit DaVita.com.